Lv4
420 积分 2021-04-08 加入
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
14天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
14天前
已完结
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
23天前
已完结
The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis
2个月前
已关闭
Targeting HER2 in the treatment of non-small cell lung cancer
2个月前
已完结
Randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor-positive, HER2-negative patients with advanced breast cancer (NorBreast-231 trial)
3个月前
已完结
A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines
3个月前
已完结
Smart strategies to overcome tumor hypoxia toward the enhancement of cancer therapy
4个月前
已完结
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines†
4个月前
已完结
Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Moving Into a New Era
4个月前
已完结
皖公网安备34019202002308
